Aternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3β

Journal of Neurochemistry

Volumn 81, Issue 5, 2002, Pages 1073-1083

  Mukai, Fumiko ^a,b   Ishiguro, Koichi ^a   Sano, Yumiko ^a   Fujita, Shinobu C ^a  

^a MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

^b Clontech Co   (Japan)

Author keywords

Glycogen synthase kinase 3; Protein kinase subdomain; Splice variant; Tau phosphorylation; Tau protein kinase

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN SERINE THREONINE KINASE; TAU PROTEIN; TAU PROTEIN KINASE 1; UNCLASSIFIED DRUG; WNT PROTEIN; GLYCOGEN SYNTHASE KINASE; GLYCOGEN SYNTHASE KINASE 3; ISOENZYME; PROTEIN KINASE (CALCIUM,CALMODULIN); TAU PROTEIN KINASE; TAU-PROTEIN KINASE;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FATE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; ANIMAL; ANTIBODY SPECIFICITY; BRAIN; CATALYSIS; CELL STRAIN COS1; CHEMICAL STRUCTURE; CYTOLOGY; ENZYME ACTIVE SITE; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PRENATAL DEVELOPMENT; RAT;

ANIMALIA;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CATALYSIS; CATALYTIC DOMAIN; CONSERVED SEQUENCE; COS CELLS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PROTEIN-SERINE-THREONINE KINASES; RATS; TRANSFECTION;

EID: 0035983533     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00918.x     Document Type: Article

References (68)

1. Two catalytic subunits of cAMP-dependent protein kinase generated by alternative RNA splicing are expressed in Aplysia neurons
2. Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology
3. Selective regulation of expression of protein kinase Cβ isozymes occurs via alternative splicing
4. 2+/calmodulin-dependent protein kinase isoforms in rat brain
5. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenes
6. Regulation of alternative splicing of protein kinase Cβ by insulin
7. The role of protein phosphorylation in the hormonal control of enzyme activity
8. Crystal structure of glycogen synthase kinase 3β: Structural basis for phosphate-primed substrate specificity and autoinhibition
9. The ste20 group kinases as regulators of MAP kinase cascades
10. Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling
11. In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase
12. Isolation of MEK5 and differential expression of alternatively spliced forms
13. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation
14. Immunohistochemistry of tau protein kinase I in the fetal rat nervous system
15. Organization and regulation of mitogen-activated protein kinase signaling pathways
16. Splicing regulation in neurons: Tinkering with cell-specific control
17. Selective interaction of JNK protein kinase isoforms with transcription factors
18. Structure of GSK3β reveals a primed phosphorylation mechanism
19. Glycogen synthase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase
20. The eukaryotic protein kinase superfamily: Kinase (catalytic) domain structure and classification
21. Regulation of GSK-3
22. Purification of glycogen synthase kinase 3 from rabbit skeletal muscle
23. Insulin and insulin-like growth factor-I regulate tau phosphorylation in cultured human neurons
24. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation
25. GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with axin
26. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease
27. A novel tubulin-dependent protein kinase forming a paired helical filament epitope on tau
28. Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments
29. Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments
30. Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments
31. Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites
32. A variant form of cyclin-dependent kinase 2 (Cdk2) in a malignantly transformed rat thyroid (FRTL-Tc) cell line
33. Alternative splice variant of γ-calmodulin-dependent protein kinase II alters activation by calmodulin
34. The stress-activated protein kinase subfamily of c-Jun kinases
35. Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA
36. Developmental expression and localisation of glycogen synthase kinase-3β in rat brain
37. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells
38. Decreased nuclear β-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice
39. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau
40. Signal transduction through β-catenin and specification of cell fate during embryogenesis
41. PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3β
42. The molecular heterogeneity of protein kinase C and its implications for cellular regulation
43. Two types of complementary DNAs of rat brain protein kinase C
44. Expression and properties of two types of protein kinase C: Alternative splicing from a single gene
45. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain
46. Inhibition of protein phosphatase 2A overrides tau proteinkinase I/glycogen synthase kinase 3β and cyclin dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse
47. Glycogen synthase kinase-3: Functions in oncogenesis and development
48. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3β
49. Control of β-catenin stability: Recognition of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts
50. Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology
51. wingless signaling acts through zeste-white 3, the Drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate
52. 2+/calmodulin-dependent protein kinase. II γ-subunit variants expressed in vascular smooth muscle, brain, and cardiomyocytes
53. Alternative pre-mRNA splicing: The logic of combinatorial control
54. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2
55. Glycogen synthase kinase-3β phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice
56. Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus
57. Inactivation'of glycogen synthase kinase-3β by phosphorylation: New kinase connections in insulin and growth-factor signalling
58. Localization and developmental changes of τ protein kinase I/glycogen synthase kinase-3β in rat brain
59. Mechanism of interferon action. cDNA structure and regulation of a novel splice site variant of the catalytic subunit of human protein kinase A from interferon-treated human cells
60. The protein kinase A catalytic subunit Cβ2: Molecular characterization and distribution of the splice variant
61. Aβ amyloidosis induces the initial stage of tau accumulation in APPsw mice
62. cDNA cloning of an alternative splicing variant of protein kinase Cδ (PKCδIII), a new truncated form of PKCδ, in rats
63. 2+/calmodulin-dependent protein kinase II with different activities
64. Structural organization of MAP-kinase signaling module by scaffold proteins in yeast and mammals
65. Isoform Cβ2, an unusual form of the bovine catalytic subunit of cAMP-dependent protein kinase
66. Molecular cloning and expression of glycogen synthase kinase-3/Factor A
67. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPKII
68. Casein kinase I α and αL: Alternative splicing-generated kinases exhibit different catalytic properties